The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Mikael Lantz

Mikael Lantz

Consultant

Mikael Lantz

Hypertyreos inducerad av jodkontrastmedel är svårbehandlad. Kan leda till fördröjd terapi av tumörsjukdom, visar två fall.

Author

  • Helene Nilsson
  • Bengt Hallengren
  • Mikael Lantz

Department/s

  • Faculty of Medicine
  • Genomics, Diabetes and Endocrinology

Publishing year

2013

Language

Swedish

Pages

1470-1472

Publication/Series

Läkartidningen

Volume

110

Issue

34-35

Document type

Journal article

Publisher

Swedish Medical Association

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 0023-7205